NH125 kills methicillin-resistant Staphylococcus aureus persisters by lipid bilayer disruption

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms and associated risks. Clin. Microbiol. Rev. 10(3), 505–520 (1997).
  Medline CASGoogle Scholar
• 2 Gorwitz RJ, Kruszon-Moran D, McAllister SK et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J. Infect. Dis. 197(9), 1226–1234 (2008).
  MedlineGoogle Scholar
• 3 Wendlandt S, Schwarz S, Silley P. Methicillin-resistant Staphylococcus aureus: a food-borne pathogen? Annu. Rev. Food Sci. Technol. 4(1), 117–139 (2013).
  Medline CASGoogle Scholar
• 4 David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 23(3), 616–687 (2010).
  Medline CASGoogle Scholar
• 5 Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7(9), 629–641 (2009).
  Medline CASGoogle Scholar
• 6 Otto M. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu. Rev. Microbiol. 64(1), 143–162 (2010).
  Medline CASGoogle Scholar
• 7 Fischbach MA, Walsh CT. Antibiotics for emerging pathogens. Science. 325(5944), 1089–1093 (2009).
  Medline CASGoogle Scholar
• 8 Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230(1), 13–18 (2004).
  Medline CASGoogle Scholar
• 9 Allison KR, Brynildsen MP, Collins JJ. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473(7346), 216–220 (2011). • Demonstrates that metabolites make persister cells susceptible to aminoglycosides.
  Medline CASGoogle Scholar
• 10 Conlon BP, Nakayasu ES, Fleck LE et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503(7476), 365–370 (2013). • Demonstrates that ADEP4 corrupts ClpP, a major protease and induces degradation of proteins, which leads to killing of S. aureus persisters.
  Medline CASGoogle Scholar
• 11 Kim W, Conery AL, Rajamuthiah R, Fuchs BB, Ausubel FM, Mylonakis E. Identification of an antimicrobial agent effective against Methicillin-resistant Staphylococcus aureus persisters using a fluorescence-based screening strategy. PLoS ONE. 10(6), e0127640 (2015). •• Provides a fluorescence-based strategy to identify antimicrobial agents effective against MRSA persisters.
  MedlineGoogle Scholar
• 12 LaFleur MD, Qi Q, Lewis K. Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob. Agents Chemother. 54(1), 39–44 (2010). • Provides an evidence that persisters are involved in chronic infectious diseases.
  Medline CASGoogle Scholar
• 13 Mulcahy LR, Burns JL, Lory S, Lewis K. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J. Bacteriol. 192(23), 6191–6199 (2010). • Additional evidence that persisters are involved in chronic infectious diseases is described in this report.
  Medline CASGoogle Scholar
• 14 Howden BP, Davies JK, Johnson PDR, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection and clinical implications. Clin. Microbiol. Rev. 23(1), 99–139 (2010).
  Medline CASGoogle Scholar
• 15 Krell T, Lacal J, Busch A, Silva-Jiménez H, Guazzaroni M-E, Ramos JL. Bacterial sensor kinases: diversity in the recognition of environmental signals. Annu. Rev. Microbiol. 64(1), 539–559 (2010).
  Medline CASGoogle Scholar
• 16 Gotoh Y, Eguchi Y, Watanabe T, Okamoto S, Doi A, Utsumi R. Two-component signal transduction as potential drug targets in pathogenic bacteria. Curr. Opin. Microbiol. 13(2), 232–239 (2010).
  Medline CASGoogle Scholar
• 17 Martin PK, Li T, Sun D, Biek DP, Schmid MB. Role in cell permeability of an essential two-component system in Staphylococcus aureus. J. Bacteriol. 181(12), 3666–3673 (1999).
  Medline CASGoogle Scholar
• 18 Sun J, Zheng L, Landwehr C, Yang J, Ji Y. Identification of a novel essential two-component signal transduction system, YhcSR, in Staphylococcus aureus. J. Bacteriol. 187(22), 7876–7880 (2005).
  Medline CASGoogle Scholar
• 19 Yamamoto K, Kitayama T, Ishida N et al. Identification and characterization of a potent antibacterial agent, NH125 against drug-resistant bacteria. Biosci. Biotechnol. Biochem. 64(4), 919–923 (2000). •• This is the first paper to identify the activity of NH125, showing it inhibits histidine protein kinases and has antimicrobial activity.
  Medline CASGoogle Scholar
• 20 Yamamoto K, Kitayama T, Minagawa S et al. Antibacterial agents that inhibit histidine protein kinase YycG of Bacillus subtilis. Biosci. Biotechnol. Biochem. 65(10), 2306–2310 (2001). • The authors report inhibition of WalK (also known as YycG) by NH125.
  Medline CASGoogle Scholar
• 21 Watanabe T, Hashimoto Y, Yamamoto K et al. Isolation and characterization of inhibitors of the essential histidine kinase, YycG in Bacillus subtilis and Staphylococcus aureus. J. Antibiot. 56(12), 1045–1052 (2003). • This report demonstrates the potential of the WalK/R system as a promising target for the development of antibiotics.
  Medline CASGoogle Scholar
• 22 Okada A, Igarashi M, Okajima T et al. Walkmycin B targets WalK (YycG), a histidine kinase essential for bacterial cell growth. J. Antibiot. 63(2), 89–94 (2010).
  Medline CASGoogle Scholar
• 23 Gotoh Y, Doi A, Furuta E et al. Novel antibacterial compounds specifically targeting the essential WalR response regulator. J. Antibiot. 63(3), 127–134 (2010).
  Medline CASGoogle Scholar
• 24 Huang R-Z, Zheng L-K, Liu H-Y et al. Thiazolidione derivatives targeting the histidine kinase YycG are effective against both planktonic and biofilm-associated Staphylococcus epidermidis. Acta Pharmacologica Sinica. 33(3), 418–425 (2012).
  MedlineGoogle Scholar
• 25 Watanabe T, Igarashi M, Okajima T et al. Isolation and characterization of signermycin B, an antibiotic that targets the dimerization domain of histidine kinase WalK. Antimicrob. Agents Chemother. 56(7), 3657–3663 (2012).
  Medline CASGoogle Scholar
• 26 Igarashi M, Watanabe T, Hashida T et al. Waldiomycin, a novel WalK-histidine kinase inhibitor from Streptomyces sp. MK844-mF10. J. Antibiot. 66(8), 459–464 (2013).
  Medline CASGoogle Scholar
• 27 Walde P, Cosentino K, Engel H, Stano P. Giant vesicles: preparations and applications. Chembiochem 11(7), 848–865 (2010). •• Provides an excellent review of GUVs and their application in a broad range of fields.
  Medline CASGoogle Scholar
• 28 Kahya N. Protein-protein and protein-lipid interactions in domain-assembly: lessons from giant unilamellar vesicles. Biochim. Biophys. Acta 1798(7), 1392–1398 (2010).
  Medline CASGoogle Scholar
• 29 Baba T, Takeuchi F, Kuroda M et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359(9320), 1819–1827 (2002).
  Medline CASGoogle Scholar
• 30 Garsin DA, Sifri CD, Mylonakis E et al. A simple model host for identifying Gram-positive virulence factors. Proc. Natl Acad. Sci. USA 98(19), 10892–10897 (2001).
  Medline CASGoogle Scholar
• 31 Junior JC, Fuchs BB, Sabino CP et al. Photodynamic and antibiotic therapy impair the pathogenesis of Enterococcus faecium in a whole animal insect model. PLoS ONE 8(2), e55926 (2013).
  MedlineGoogle Scholar
• 32 Smith MG, Gianoulis TA, Pukatzki S et al. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 21(5), 601–614 (2007).
  Medline CASGoogle Scholar
• 33 Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM. Common virulence factors for bacterial pathogenicity in plants and animals. Science 268(5219), 1899–1902 (1995).
  Medline CASGoogle Scholar
• 34 Rajamuthiah R, Jayamani E, Conery AL et al. A defensin from the model beetle Tribolium castaneum acts synergistically with telavancin and daptomycin against multidrug resistant Staphylococcus aureus. PLoS ONE 10(6), e0128576 (2015).
  MedlineGoogle Scholar
• 35 Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 9th edition. CLSI document M07-A9. Wayne, PA, USA.
  Google Scholar
• 36 Angelova MI, Soléau S, Méléard P, Faucon F, Bothorel P. Preparation of giant vesicles by external AC electric fields. Kinetics and applications. Prog. Colloid Polym. Sci. 89, 127–131 (1992).
  CASGoogle Scholar
• 37 Chen Y-F, Sun T-L, Sun Y, Huang HW. Interaction of daptomycin with lipid bilayers: a lipid extracting effect. Biochemistry 53(33), 5384–5392 (2014).
  Medline CASGoogle Scholar
• 38 Mertins O, Dimova R. Insights on the interactions of chitosan with phospholipid vesicles. Part II: Membrane stiffening and pore formation. Langmuir 29(47), 14552–14559 (2013).
  Medline CASGoogle Scholar
• 39 Dubrac S, Msadek T. Identification of genes controlled by the essential YycG/YycF two-component system of Staphylococcus aureus. J. Bacteriol. 186(4), 1175–1181 (2004).
  Medline CASGoogle Scholar
• 40 Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J. Infect. Dis. 197(8), 1079–1081 (2008).
  MedlineGoogle Scholar
• 41 Howell A, Dubrac S, Noone D, Varughese KI, Devine K. Interactions between the YycFG and PhoPR two-component systems in Bacillus subtilis: the PhoR kinase phosphorylates the non-cognate YycF response regulator upon phosphate limitation. Mol. Microbiol. 59(4), 1199–1215 (2006).
  Medline CASGoogle Scholar
• 42 Gueriri I, Bay S, Dubrac S, Cyncynatus C, Msadek T. The Pta-AckA pathway controlling acetyl phosphate levels and the phosphorylation state of the DegU orphan response regulator both play a role in regulating Listeria monocytogenes motility and chemotaxis. Mol. Microbiol. 70(6), 1342–1357 (2008).
  Medline CASGoogle Scholar
• 43 McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action and resistance. Clin. Microbiol. Rev. 12(1), 147–179 (1999). • Provides a thoughtful review of various antiseptics and disinfectants, including BAC and their modes of action.
  Medline CASGoogle Scholar
• 44 Gilbert P, Moore LE. Cationic antiseptics: diversity of action under a common epithet. J. Appl. Microbiol. 99(4), 703–715 (2005). •• Reviews cationic antiseptics including BAC and their modes of action.
  Medline CASGoogle Scholar
• 45 Tamba Y, Yamazaki M. Single giant unilamellar vesicle method reveals effect of antimicrobial peptide magainin 2 on membrane permeability. Biochemistry 44(48), 15823–15833 (2005).
  Medline CASGoogle Scholar
• 46 Ambroggio EE, Separovic F, Bowie JH, Fidelio GD, Bagatolli LA. Direct Visualization of Membrane Leakage Induced by the Antibiotic Peptides: Maculatin, Citropin and Aurein. Biophys. J. 89(3), 1874–1881 (2005).
  Medline CASGoogle Scholar
• 47 Lee C-C, Sun Y, Qian S, Huang HW. Transmembrane pores formed by human antimicrobial peptide LL-37. Biophys. J. 100(7), 1688–1696 (2011).
  Medline CASGoogle Scholar
• 48 Wang Y, Corbitt TS, Jett SD et al. Direct visualization of bactericidal action of cationic conjugated polyelectrolytes and oligomers. Langmuir 28(1), 65–70 (2012).
  MedlineGoogle Scholar
• 49 Ganewatta MS, Chen YP, Wang J et al. Bio-inspired resin acid-derived materials as anti-bacterial resistance agents with unexpected activities. Chem. Sci. 5(5), 2011–2016 (2014).
  CASGoogle Scholar
• 50 Caillon L, Killian JA, Lequin O, Khemtémourian L. Biophysical investigation of the membrane-disrupting mechanism of the antimicrobial and amyloid-like peptide dermaseptin S9. PLoS ONE 8(10), e75528 (2013).
  Medline CASGoogle Scholar
• 51 Cadwallader DE, Ansel HC. Hemolysis of erythrocytes by antibacterial preservatives II. Quaternary ammonium salts. J. Pharm. Sci. 54(7), 1010–1012 (1965).
  Medline CASGoogle Scholar
• 52 Cha SH, Lee JS, Oum BS, Kim CD. Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro. Clin. Exp. Ophthalmol. 32(2), 180–184 (2004).
  MedlineGoogle Scholar
• 53 Ho C-Y, Wu M-C, Lan M-Y, Tan C-T, Yang A-H. In vitro effects of preservatives in nasal sprays on human nasal epithelial cells. Am. J. Rhinol. 22(2), 125–129 (2008).
  MedlineGoogle Scholar
• 54 Lewis K. Persister cells. Annu. Rev. Microbiol. 64(1), 357–372 (2010). •• A considered expert in the field, Lewis, provides a review of the biological properties of persisters and mechanism of persister formation.
  Medline CASGoogle Scholar
• 55 Helaine S, Kugelberg E. Bacterial persisters: formation, eradication and experimental systems. Trends Microbiol. 22(7), 417–424 (2014). • Reviews current strategies to kill persisters.
  Medline CASGoogle Scholar
• 56 Spoering AL, Lewis K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183(23), 6746–6751 (2001).
  Medline CASGoogle Scholar
• 57 Dubrac S, Boneca IG, Poupel O, Msadek T. New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus. J. Bacteriol. 189(22), 8257–8269 (2007).
  Medline CASGoogle Scholar
• 58 Huang R-Z, Zheng L-K, Liu H-Y et al. Thiazolidione derivatives targeting the histidine kinase YycG are effective against both planktonic and biofilm-associated Staphylococcus epidermidis. Acta Pharmacol. Sin. 33(3), 418–425 (2012).
  MedlineGoogle Scholar
• 59 Hurdle JG, O'Neill AJ, Chopra I, Lee RE. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat. Rev. Microbiol. 9(1), 62–75 (2011). •• Reviews membrane-active agents and their possibility for treating persistent infection.
  Medline CASGoogle Scholar
• 60 Straus SK, Hancock REW. Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim. Biophys. Acta 1758(9), 1215–1223 (2006).
  Medline CASGoogle Scholar
• 61 Figueroa DA, Mangini E, Amodio-Groton M et al. Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program. Clin. Infect. Dis. 49(2), 177–180 (2009).
  Medline CASGoogle Scholar
• 62 Kostrominova TY, Coleman S, Oleson FB, Faulkner JA, Larkin LM. Effect of daptomycin on primary rat muscle cell cultures in vitro. In vitro Cell. Dev. Biol.-Animal 46(7), 613–618 (2010).
  Medline CASGoogle Scholar
• 63 Koh J-J, Qiu S, Zou H et al. Rapid bactericidal action of alpha-mangostin against MRSA as an outcome of membrane targeting. Biochim. Biophys. Acta 1828(2), 834–844 (2013).
  Medline CASGoogle Scholar
• 64 Zou H, Koh J-J, Li J et al. Design and synthesis of amphiphilic xanthone-based, membrane-targeting antimicrobials with improved membrane selectivity. J. Med. Chem. 56(6), 2359–2373 (2013).
  Medline CASGoogle Scholar
• 65 Müller G, Kramer A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J. Antimicrob. Chemother. 61(6), 1281–1287 (2008).
  Medline CASGoogle Scholar
• 66 Dimova R, Aranda S, Bezlyepkina N, Nikolov V, Riske KA, Lipowsky R. A practical guide to giant vesicles. Probing the membrane nanoregime via optical microscopy. J. Phys. Condens. Matter. 18(28), S1151–S1176 (2006).
  Medline CASGoogle Scholar
• 67 Sudbrack TP, Archilha NL, Itri R, Riske KA. Observing the solubilization of lipid bilayers by detergents with optical microscopy of GUVs. J. Phys. Chem. B. 115(2), 269–277 (2011). • Describes how detergents solubilize GUVs.
  Medline CASGoogle Scholar
• 68 Lichtenberg D, Ahyayauch H, Goñi FM. The mechanism of detergent solubilization of lipid bilayers. Biophys. J. 105(2), 289–299 (2013). • Describes the mechanisms of detergent solubilization of lipid bilayers and the importance of the flip-flop rate of a detergent in the solubilization.
  Medline CASGoogle Scholar
• 69 Kragh-Hansen U, le Maire M, Møller JV. The mechanism of detergent solubilization of liposomes and protein-containing membranes. Biophys. J. 75(6), 2932–2946 (1998).
  Medline CASGoogle Scholar
• 70 Stuart MCA, Boekema EJ. Two distinct mechanisms of vesicle-to-micelle and micelle-to-vesicle transition are mediated by the packing parameter of phospholipid–detergent systems. Biochim. Biophys. Acta 1768(11), 2681–2689 (2007).
  Medline CASGoogle Scholar
• 71 Cócera M, Lopez O, Coderch L, Parra JL, la Maza de A. Influence of the level of ceramides on the permeability of stratum corneum lipid liposomes caused by a C12-betaine/sodium dodecyl sulfate mixture. Int. J. Pharm. 183(2), 165–173 (1999).
  Medline CASGoogle Scholar
• 72 Heerklotz H. Membrane stress and permeabilization induced by asymmetric incorporation of compounds. Biophys. J. 81(1), 184–195 (2001).
  Medline CASGoogle Scholar
• 73 Roth BL, Poot M, Yue ST, Millard PJ. Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain. Appl. Environ. Microbiol. 63(6), 2421–2431 (1997). • The first to introduce a membrane-impermeable DNA-binding dye, SYTOX Green.
  Medline CASGoogle Scholar